Abstract
Objectives: In order to ensure safety of the cell-based therapy for bone regeneration, we examined in vivo biodistribution of locally or systemically transplanted osteoblast-like cells generated from bone marrow (BM) derived mononuclear cells. Methods: BM cells obtained from a total of 13 Sprague-Dawley (SD) green fluorescent protein transgenic (GFP-Tg) rats were culture-expanded in an osteogenic differentiation medium for three weeks. Osteoblast-like cells were then locally transplanted with collagen scaffolds to the rat model of segmental bone defect. Donor cells were also intravenously infused to the normal Sprague-Dawley (SD) rats for systemic biodistribution. The flow cytometric and histological analyses were performed for cellular tracking after transplantation. Results: Locally transplanted donor cells remained within the vicinity of the transplantation site without migrating to other organs. Systemically administered large amounts of osteoblast-like cells were cleared from various organ tissues within three days of transplantation and did not show any adverse effects in the transplanted rats. Conclusions: We demonstrated a precise assessment of donor cell biodistribution that further augments prospective utility of regenerative cell therapy.
Original language | English |
---|---|
Pages (from-to) | 76-81 |
Number of pages | 6 |
Journal | Bone and Joint Research |
Volume | 3 |
Issue number | 3 |
DOIs | |
Publication status | Published - Mar 2014 |
Externally published | Yes |
All Science Journal Classification (ASJC) codes
- Surgery
- Orthopedics and Sports Medicine